Virginia Regulatory Town Hall
Virginia Department of Health
State Board of Health
Prescription Drug Price Transparency Regulation [12 VAC 5 ‑ 219]
Public Comment Forum
On this Action: 
Promulgation of New Regulation to Implement Chapter 304 of the 2021 Acts of Assembly, Special Session I
Emergency/NOIRA Stage - View the regulatory documents

CLOSED     Opened on 1/17/2022 and Ended on 2/16/2022

More about public comment forums and policies
red ball View all comments    

Comment Title Commenter
PhRMA Comments re Chapter 219 Prescription Drug Price Transparency Regulation PhRMA  2/16/22  5:15 pm
Request Clarification of Manufacturer and Reporting Entity. Pharma Solutions USA, Inc., Sumeet Singh CEO & Deneen Fumich, Director  2/16/22  11:08 am
Suggestion to exempt Contract Manufacturing Organizations from requirement Gil Roth, Pharma & Biophama Outsourcing Association (PBOA)  2/15/22  5:04 pm
Recommend explicitly excl CMOs [and similar org] who manufacture but do not market or set prices Catalent Pharma Solutions, Inc.  2/14/22  6:21 pm

Trouble posting comments? These pages have been tested with multiple versions of all the major browsers. If you have trouble: (1) try another computer if you have access to one, (2) try another browser if your computer has one installed (3) contact Town Hall support staff for assistance.